{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:32:21Z","timestamp":1755793941581},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Big Data"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The burden of gastric cancer (GC) should be further clarified worldwide, and helped us to understand the current situation of GC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In the present study, we estimated disability-adjusted life-years (DALYs) and mortality rates attributable to several major GC risk factors, including smoking, dietary risk, and behavioral risk. In addition, we evaluated the incidence rate and trends of incidence-based mortality (IBM) due to GC in the United States (US) during 1992\u20132018.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Globally, GC incidences increased from 883,395 in 1990 to 1,269,805 in 2019 while GC-associated mortality increased from 788,316 in 1990 to 957,185 in 2019. In 2019, the age-standardized rate (ASR) of GC exhibited variations around the world, with Mongolia having the highest observed ASR (43.7 per 100,000), followed by Bolivia (34 per 100,000) and China (30.6 per 100,000). A negative association was found among estimated annual percentage change (EAPC) and ASR (age-standardized incidence rate (ASIR): r\u2009=\u2009\u2212\u20090.28, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; age-standardized death rate (ASDR): r\u2009=\u2009\u2009\u2212\u20090.19, <jats:italic>p<\/jats:italic>\u2009=\u20090.005). There were 74,966 incidences of GC and 69,374 GC-related deaths recorded between 1992 and 2018. The significant decrease in GC incidences as well as decreasing trends in IBM of GC were first detected in 1994. The GC IBM significantly increased at a rate of 35%\/y from 1992 to 1994 (95% CI 21.2% to 50.4%\/y), and then begun to decrease at a rate of \u2212\u20091.4%\/y from 1994 to 2018 (95% CI \u2212\u20091.6% to \u2212\u20091.2%\/y).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These findings mirror the global disease burden of GC and are important for development of targeted prevention strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40537-024-00907-8","type":"journal-article","created":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T09:01:53Z","timestamp":1712998913000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The differences in gastric cancer epidemiological data between SEER and GBD: a joinpoint and age-period-cohort analysis"],"prefix":"10.1186","volume":"11","author":[{"given":"Zenghong","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengke","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,13]]},"reference":[{"issue":"10251","key":"907_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635\u201348.","journal-title":"Lancet"},{"issue":"1","key":"907_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"M Arnold","year":"2020","unstructured":"Arnold M, Abnet CC, Neale RE, et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159(1):335-349.e15.","journal-title":"Gastroenterology"},{"issue":"8","key":"907_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrgastro.2017.53","volume":"14","author":"N Padmanabhan","year":"2017","unstructured":"Padmanabhan N, Ushijima T, Tan P. How to stomach an epigenetic insult: the gastric cancer epigenome. Nat Rev Gastroenterol Hepatol. 2017;14(8):467\u201378.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"907_CR4","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/ijc.29670","volume":"137","author":"F Bray","year":"2015","unstructured":"Bray F, Ferlay J, Laversanne M. Cancer incidence in five continents: inclusion criteria, highlights from Volume X and the global status of cancer registration. Int J Cancer. 2015;137:2060\u201371.","journal-title":"Int J Cancer"},{"issue":"5","key":"907_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023;20(5):338\u201349.","journal-title":"Nat Rev Clin Oncol"},{"key":"907_CR6","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2020004","volume":"42","author":"J Poorolajal","year":"2020","unstructured":"Poorolajal J, Moradi L, Mohammadi Y, Cheraghi Z, Gohari-Ensaf F. Risk factors for stomach cancer: a systematic review and meta-analysis. Epidemiol Health. 2020;42: e2020004.","journal-title":"Epidemiol Health"},{"issue":"3","key":"907_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3322\/caac.21766","volume":"73","author":"V Wadhwa","year":"2023","unstructured":"Wadhwa V, Patel N, Grover D, Ali FS, Thosani N. Interventional gastroenterology in oncology. CA Cancer J Clin. 2023;73(3):286\u2013319.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"907_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00004836-200101000-00010","volume":"32","author":"S Ishigami","year":"2001","unstructured":"Ishigami S, Natsugoe S, Hokita S, Che X, Tokuda K, Nakajo A, et al. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19\u20139 levels in gastric cancer. J Clin Gastroenterol. 2001;32(1):41\u20134.","journal-title":"J Clin Gastroenterol"},{"key":"907_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103841","volume":"181","author":"MJ L\u00f3pez","year":"2023","unstructured":"L\u00f3pez MJ, Carbajal J, Alfaro AL, Saravia LG, Zanabria D, Araujo JM, Quispe L, Zevallos A, Buleje JL, Cho CE, Sarmiento M, Pinto JA, Fajardo W. Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol. 2023;181: 103841.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"907_CR10","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"Global Burden of Disease Cancer Collaboration","year":"2019","unstructured":"Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749\u201368.","journal-title":"JAMA Oncol"},{"key":"907_CR11","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/ijc.30835","volume":"141","author":"G Luo","year":"2017","unstructured":"Luo G, Zhang Y, Guo P, Wang L, Huang Y, Li K. Global patterns and trends in stomach cancer incidence: age, period and birth cohort analysis. Int J Cancer. 2017;141:1333\u201344.","journal-title":"Int J Cancer"},{"key":"907_CR12","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1001\/jama.2010.496","volume":"303","author":"WF Anderson","year":"2010","unstructured":"Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS, Rabkin CS. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010;303:1723\u20138.","journal-title":"JAMA"},{"issue":"44","key":"907_CR13","doi-asserted-by":"publisher","first-page":"7881","DOI":"10.3748\/wjg.v23.i44.7881","volume":"23","author":"MC Tsai","year":"2017","unstructured":"Tsai MC, Wang CC, Lee HL, Peng CM, Yang TW, Chen HY, et al. Health disparities are associated with gastric cancer mortality-to-incidence ratios in 57 countries. World J Gastroenterol. 2017;23(44):7881\u20137.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"907_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/s1470-2045(03)01170-7","volume":"4","author":"HQ Xiong","year":"2003","unstructured":"Xiong HQ, Gunderson LL, Yao J, Ajani JA. Chemoradiation for resectable gastric cancer. Lancet Oncol. 2003;4(8):498\u2013505. https:\/\/doi.org\/10.1016\/s1470-2045(03)01170-7.","journal-title":"Lancet Oncol"},{"issue":"7","key":"907_CR15","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/1097-0142(19950401)75:7<1734::AID-CNCR2820750729>3.0.CO;2-E","volume":"75","author":"W Lawrence Jr","year":"1995","unstructured":"Lawrence W Jr, Menck HR, Steele GD Jr, Winchester DP. The National Cancer Data Base report on gastric cancer. Cancer. 1995;75(7):1734\u201344.","journal-title":"Cancer"},{"issue":"1","key":"907_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.17849\/insm-48-1-1-19.1","volume":"48","author":"AF Milano","year":"2019","unstructured":"Milano AF. 20-Year comparative survival and mortality of cancer of the stomach by age, sex, race, stage, grade, cohort entry time-period, disease duration & selected ICD-O-3 oncologic phenotypes: a systematic review of 157,258 cases for diagnosis years 1973-2014: (SEER*Stat 8.3.4). J Insur Med. 2019;48(1):5\u201323.","journal-title":"J Insur Med"},{"issue":"12","key":"907_CR17","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1016\/j.cgh.2020.04.085","volume":"18","author":"MK Pourmousavi","year":"2020","unstructured":"Pourmousavi MK, Wang R, Kerdsirichairat T, Kamal A, Akshintala VS, Hajiyeva G, et al. Comparable cancer-specific mortality of patients with early gastric cancer treated with endoscopic therapy vs surgical resection. Clin Gastroenterol Hepatol. 2020;18(12):2824-2832.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"907_CR18","unstructured":"Global Burden of Disease Collaborative Network Global Burden of Disease Study 2019 (GBD 2019) Results Institute for Health Metrics and Evaluation (IHME), Seattle, United States (2019). http:\/\/ghdx.healthdata.org\/gbd-results-tool"},{"issue":"3","key":"907_CR19","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1212\/WNL.0000000000013115","volume":"98","author":"Q Ding","year":"2022","unstructured":"Ding Q, Liu S, Yao Y, Liu H, Cai T, Han L. Global, regional, and national burden of ischemic stroke, 1990\u20132019. Neurology. 2022;98(3):e279\u201390.","journal-title":"Neurology"},{"key":"907_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","volume":"126","author":"Q Liu","year":"2020","unstructured":"Liu Q, He H, Yang J, Feng X, Zhao F, Lyu J. Changes in the global burden of depression from 1990 to 2017: findings from the Global Burden of Disease study. J Psychiatr Res. 2020;126:134\u201340.","journal-title":"J Psychiatr Res"},{"issue":"4","key":"907_CR21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","volume":"70","author":"Z Liu","year":"2019","unstructured":"Liu Z, Jiang Y, Yuan H, Fang Q, Cai N, Suo C, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70(4):674\u201383.","journal-title":"J Hepatol"},{"issue":"6","key":"907_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1634\/theoncologist.8-6-541","volume":"8","author":"LA Gloeckler Ries","year":"2003","unstructured":"Gloeckler Ries LA, Reichman ME, Lewis DR, Hankey BF, Edwards BK. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist. 2003;8(6):541\u201352.","journal-title":"Oncologist"},{"issue":"6","key":"907_CR23","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa121","volume":"105","author":"KL Yan","year":"2020","unstructured":"Yan KL, Li S, Tseng CH, Kim J, Nguyen DT, Dawood NB, et al. Rising incidence and incidence-based mortality of thyroid cancer in California, 2000\u20132017. J Clin Endocrinol Metab. 2020;105(6): dgaa121.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"907_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351.","journal-title":"Stat Med"},{"issue":"4","key":"907_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00127-020-01988-5","volume":"56","author":"T Okui","year":"2021","unstructured":"Okui T. An age-period-cohort analysis for prevalence of common psychiatric disorders in Japan, 1999\u20132017. Soc Psychiatry Psychiatr Epidemiol. 2021;56(4):639\u201348.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"1","key":"907_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40364-021-00340-6","volume":"9","author":"X Yang","year":"2021","unstructured":"Yang X, Zhang T, Zhang H, Sang S, Chen H, Zuo X. Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia. Biomark Res. 2021;9(1):84.","journal-title":"Biomark Res"},{"issue":"27","key":"907_CR27","doi-asserted-by":"publisher","first-page":"19427","DOI":"10.18632\/oncotarget.24827","volume":"9","author":"M Cis\u0142o","year":"2018","unstructured":"Cis\u0142o M, Filip AA, Arnold Offerhaus GJ, Cise\u0142 B, Rawicz-Pruszy\u0144ski K, Skierucha M, et al. Distinct molecular subtypes of gastric cancer: from Laur\u00e9n to molecular pathology. Oncotarget. 2018;9(27):19427\u201342.","journal-title":"Oncotarget"},{"issue":"1","key":"907_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1158\/1055-9965.EPI-11-0834","volume":"21","author":"MC Camargo","year":"2012","unstructured":"Camargo MC, Goto Y, Zabaleta J, Morgan DR, Correa P, Rabkin CS. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2012;21(1):20\u201338.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"907_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/CEJ.0b013e3282f521e4","volume":"17","author":"C Persson","year":"2008","unstructured":"Persson C, Inoue M, Sasazuki S, Kurahashi N, Iwasaki M, Ye W, et al. Female reproductive factors and the risk of gastric cancer in a large-scale population-based cohort study in Japan (JPHC study). Eur J Cancer Prev. 2008;17(4):345\u201353.","journal-title":"Eur J Cancer Prev"},{"issue":"2","key":"907_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3748\/wjg.v16.i2.256","volume":"16","author":"HW Chung","year":"2010","unstructured":"Chung HW, Noh SH, Lim JB. Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol. 2010;16(2):256\u201363.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"907_CR31","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1053\/j.gastro.2009.05.001","volume":"137","author":"G Murphy","year":"2009","unstructured":"Murphy G, Pfeiffer R, Camargo MC, Rabkin CS. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009;137(3):824\u201333.","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"907_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2036.2004.01985.x","volume":"20","author":"S Kato","year":"2004","unstructured":"Kato S, Matsukura N, Togashi A, Masuda G, Matsuda N, Yamada N, et al. Sex differences in mucosal response to Helicobacter pylori infection in the stomach and variations in interleukin-8, COX-2 and trefoil factor family 1 gene expression. Aliment Pharmacol Ther. 2004;20(Suppl 1):17\u201324.","journal-title":"Aliment Pharmacol Ther"},{"key":"907_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/oxfordjournals.epirev.a036288","volume":"8","author":"CP Howson","year":"1986","unstructured":"Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1\u201327.","journal-title":"Epidemiol Rev"},{"issue":"6","key":"907_CR34","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/bjs.1800760604","volume":"76","author":"WH Allum","year":"1989","unstructured":"Allum WH, Powell DJ, McConkey CC, Fielding JW. Gastric cancer: a 25-year review. Br J Surg. 1989;76(6):535\u201340.","journal-title":"Br J Surg"},{"issue":"9","key":"907_CR35","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3390\/nu14091764","volume":"14","author":"E Bouras","year":"2022","unstructured":"Bouras E, Tsilidis KK, Triggi M, Siargkas A, Chourdakis M, Haidich AB. Diet and risk of gastric cancer: an umbrella review. Nutrients. 2022;14(9):1764.","journal-title":"Nutrients"},{"key":"907_CR36","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/oemed-2011-100071","volume":"69","author":"M Santiba\u00f1ez","year":"2012","unstructured":"Santiba\u00f1ez M, Alguacil J, de la Hera MG, Navarrete-Mu\u00f1oz EM, Llorca J, Aragon\u00e9s N, Kauppinen T, Vioque J. Occupational exposures and risk of stomach cancer by histological type. Occup Environ Med. 2012;69:268\u201375.","journal-title":"Occup Environ Med"},{"issue":"3","key":"907_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1053\/j.gastro.2019.10.019","volume":"158","author":"S Kumar","year":"2020","unstructured":"Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS. Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: a large cohort study. Gastroenterology. 2020;158(3):527-536.e7.","journal-title":"Gastroenterology"},{"key":"907_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"907_CR39","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.3390\/ijms21114012","volume":"21","author":"J Machlowska","year":"2020","unstructured":"Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012.","journal-title":"Int J Mol Sci"},{"key":"907_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-018-0466-9","volume":"25","author":"WL Chang","year":"2018","unstructured":"Chang WL, Yeh YC, Sheu BS. The impacts of H. pylori virulence factors on the development of gastroduodenal diseases. J Biomed Sci. 2018;25:1\u20139.","journal-title":"J Biomed Sci"},{"issue":"8","key":"907_CR41","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/clinchem\/hvad081","volume":"69","author":"SM Shakir","year":"2023","unstructured":"Shakir SM, Shakir FA, Couturier MR. Updates to the diagnosis and clinical management of Helicobacter pylori infections. Clin Chem. 2023;69(8):869\u201380.","journal-title":"Clin Chem"},{"issue":"5","key":"907_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2471\/BLT.12.108092","volume":"91","author":"I Funatogawa","year":"2013","unstructured":"Funatogawa I, Funatogawa T, Yano E. Trends in smoking and lung cancer mortality in Japan, by birth cohort, 1949\u20132010. Bull World Health Organ. 2013;91(5):332\u201340.","journal-title":"Bull World Health Organ"},{"issue":"5","key":"907_CR43","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1470-2045(10)70070-X","volume":"11","author":"I Songun","year":"2010","unstructured":"Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439\u201349.","journal-title":"Lancet Oncol"},{"key":"907_CR44","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/jso.23635","volume":"110","author":"RA Snyder","year":"2014","unstructured":"Snyder RA, Penson DF, Ni S, Koyama T, Merchant NB. Trends in the use of evidence-based therapy for resectable gastric cancer. J Surg Oncol. 2014;110:285\u201390.","journal-title":"J Surg Oncol"},{"issue":"19","key":"907_CR45","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1200\/JCO.2011.36.7136","volume":"30","author":"SR Smalley","year":"2012","unstructured":"Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol. 2012;30(19):2327\u201333.","journal-title":"J Clin Oncol"},{"issue":"22","key":"907_CR46","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074\u201384.","journal-title":"N Engl J Med"},{"issue":"5","key":"907_CR47","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S1470-2045(18)30132-3","volume":"19","author":"A Cats","year":"2018","unstructured":"Cats A, Jansen EPM, van Grieken NCT, Sikorska K, Lind P, Nordsmark M, et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Lancet Oncol. 2018;19(5):616\u201328.","journal-title":"Lancet Oncol"},{"issue":"6","key":"907_CR48","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00423-010-0738-7","volume":"396","author":"K Ott","year":"2011","unstructured":"Ott K, Lordick F, Blank S, B\u00fcchler M. Gastric cancer: surgery in 2011. Langenbecks Arch Surg. 2011;396(6):743\u201358.","journal-title":"Langenbecks Arch Surg"}],"container-title":["Journal of Big Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40537-024-00907-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40537-024-00907-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40537-024-00907-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T10:03:24Z","timestamp":1713002604000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalofbigdata.springeropen.com\/articles\/10.1186\/s40537-024-00907-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,13]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["907"],"URL":"https:\/\/doi.org\/10.1186\/s40537-024-00907-8","relation":{},"ISSN":["2196-1115"],"issn-type":[{"value":"2196-1115","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,13]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study not need institutional review board or ethics committee approval as the data all download from public free database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}